Revealing imatinib-kinase specificity via analyzing changes in protein dynamics and computing molecular binding...

Area of Science:

• Biochemistry
• Computational Biology
• Pharmacology

Background:

• Drug promiscuity, where a single drug targets multiple proteins, offers therapeutic potential but poses challenges in understanding binding mechanisms.
• Imatinib, a successful targeted therapy, exhibits varied affinities for different kinases, yet its precise binding determinants remain elusive.
• Understanding kinase binding specificity is crucial for drug repurposing and designing novel therapeutics.

Purpose of the Study:

• To elucidate the molecular determinants governing imatinib's binding specificity across various kinases.
• To develop a predictive computational approach for forecasting drug-kinase interactions.
• To explore the potential of drug repurposing by understanding off-target binding mechanisms.

Main Methods:

• All-atom molecular dynamics simulations in explicit solvent were employed.
• Analyses included molecular thermodynamics, force distribution, residue sidechain dihedral correlations, and principal component analysis.
• Protein-ligand interaction networks and kinase "breathing motions" were investigated.

Main Results:

• Computational findings align with experimental data on imatinib affinity and binding.
• A global protein network analysis successfully predicted imatinib's binding specificity.
• Changes in sidechain correlations and secondary motif dynamics correlate with binding affinity.

Conclusions:

• Residue correlation, force interactions, and principal components effectively predict imatinib-kinase binding specificity.
• This study provides a framework for repurposing existing drugs and designing new high-affinity binders.
• Understanding dynamic protein-ligand interactions is key to optimizing drug efficacy and minimizing off-target effects.